Long-Term Results of Lamivudine Monotherapy in Korean Patients with HBeAg-Positive Chronic Hepatitis B: Response and Relapse Rates, and Factors Related to Durability of HBeAg Seroconversion-Reference-Cited by-同舟云学术

Long-Term Results of Lamivudine Monotherapy in Korean Patients with HBeAg-Positive Chronic Hepatitis B: Response and Relapse Rates, and Factors Related to Durability of HBeAg Seroconversion

Published:2005 Issue:6 Volume:48 Page:341-349
ISSN:0300-5526
Container-title:Intervirology
language:en
Short-container-title:Intervirology

Author:

Yoon Seung Kew,Jang Jeong Won,Kim Chang Wook,Bae Si Hyun,Choi Jong Young,Choi Sang Wook,Lee Young Sok,Lee Chang Don,Chung Kyu Won,Sun Hee Sik,Kim Boo Sung

Publisher

S. Karger AG

Subject

Infectious Diseases,Virology

Reference35 articles.

1. Inhibition of the replication of hepatitis B virus in vitro by 2',3'-dideoxy-3'-thiacytidine and related analogues.

2. A One-Year Trial of Lamivudine for Chronic Hepatitis B

3. Lamivudine as Initial Treatment for Chronic Hepatitis B in the United States

4. Extended lamivudine treatment in patients with chronic hepatitis B enhances hepatitis B e antigen seroconversion rates: Results after 3 years of therapy

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Methodological challenges of performing meta-analyses to compare the risk of hepatocellular carcinoma between chronic hepatitis B treatments;Journal of Hepatology;2022-01

2. Meta-omics characteristics of intestinal microbiota associated to HBeAg seroconversion induced by oral antiviral therapy;Scientific Reports;2021-02-05

3. Improving the Prediction of Relapse After Nucleos(t)ide Analogue Discontinuation in Patients With Chronic Hepatitis B;Clinical Infectious Diseases;2021-01-08

4. Dynamic profile of the HBeAg-anti-HBe system in acute and chronic hepatitis B virus infection: A clinical-laboratory approach;Molecular Biology Reports;2020-12-09

5. AASLD guidelines for treatment of chronic hepatitis B;Hepatology;2015-11-13